VANCOUVER, BC / ACCESS Newswire / February 6, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned ...

Onco is actively exploring how to synergize SynoGraph's advanced analytical capabilities to support Onco's goal of refining oncology treatment strategies, identifying key biomarkers, and ...